A thyroid medicine recall has received the FDA’s highest-risk classification after testing found one lot of Thyroid Tablets, USP 30 mg coul...

Vitruvias Therapeutics thyroid tablet recall: The FDA has issued a serious Class I recall for one lot of Vitruvias Therapeutics thyroid tab...

Indian equity markets experienced volatility, with the Nifty 50 extending its losing streak for four weeks. Escalating US-Iran hostilities ...

Vitruvias Therapeutics has announced a voluntary recall of its thyroid tablets after tests indicated the potential for superpotency, which ...

USPS ⁠has a roughly $80 billion budget, and Amazon represented $6 billion in annual revenue to the agency, according to two people familiar...

Amazon has started a new doorstep return service with USPS that lets shoppers return packages from home. The option is available in some ar...

The United States Postal Service announced all 31,000 post offices will close nationwide on October 13, 2025, for Columbus Day, a federal h...

USPS holiday shipping: USPS temporary price hikes begin October 5, 2025, affecting most express mail services until January 18, 2026, to co...

Alembic Pharmaceuticals has received the United States Food and Drug Administration approval. The approval allows them to market Carbamazep...

The reforms are aimed at refining the service standards for first-class mail, marketing mail, periodicals, and package services. The USPS h...

This comes as the ministry has observed that many manufacturers, packers and importers are not making important declarations prominently on...

As per the report, Torrent Pharma Inc is recalling 17,088 bottles of Losartan Potassium /Hydrochlorothiazide tablets, USP 50mg/12.5mg from ...

The US-based arm of Torrent Pharmaceuticals is recalling 133,992 bottles of Losartan Potassium tablets USP in the strength of 25 mg.

In the textile sector, competition is growing tremendously, but a lot of Indian entrepreneurs are entering into the field and they are stil...

To date, Aurobindo Pharma USA Inc has not received any reports of adverse events related to this recall, the release said.

According to a letter issued to the USFDA, the recall of Ampicillin and Sulbactam has been initiated due to customer complaints of the pres...

Jubilant Life Sciences said it has received approvals from the US health regulator for 4 products that target CNS and CVS therapeutic areas.